Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore D Koreckij

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Spinal Disorders & Techniques|July 15, 2015
Degenerative SpondylolisthesisTheodore D Koreckij, Jeffrey S Fischgrund
Current Cancer Drug Targets|March 12, 2009
Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayTodd M Morgan, Theodore D Koreckij, Eva Corey
The Journal of the American Academy of Orthopaedic Surgeons|October 5, 2018
Cervical Disk ArthroplastyTheodore D Koreckij, Sapan D Gandhi, Daniel K Park
Spine|April 30, 2016
Retropharyngeal Steroids and Dysphagia Following Multilevel Anterior Cervical SurgeryTheodore D Koreckij, Abigail A Davidson, Kevin C Baker, et al.
The Prostate|November 26, 2009
Low dose, alternating electric current inhibits growth of prostate cancerTheodore D Koreckij, Charles Hill, Larry Azure, et al.
The Prostate|June 29, 2010
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viabilityColm Morrissey, Alex Dowell, Theodore D Koreckij, et al.
Molecular Cancer|July 6, 2010
Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral bloodMatthias Jost, John R Day, Ryan Slaughter, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
HE3235 inhibits growth of castration-resistant prostate cancerTheodore D Koreckij, Richard J Trauger, Robert Bruce Montgomery, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Spinal Disorders & Techniques|July 15, 2015
Degenerative SpondylolisthesisTheodore D Koreckij, Jeffrey S Fischgrund
Current Cancer Drug Targets|March 12, 2009
Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayTodd M Morgan, Theodore D Koreckij, Eva Corey
The Journal of the American Academy of Orthopaedic Surgeons|October 5, 2018
Cervical Disk ArthroplastyTheodore D Koreckij, Sapan D Gandhi, Daniel K Park
Spine|April 30, 2016
Retropharyngeal Steroids and Dysphagia Following Multilevel Anterior Cervical SurgeryTheodore D Koreckij, Abigail A Davidson, Kevin C Baker, et al.
The Prostate|November 26, 2009
Low dose, alternating electric current inhibits growth of prostate cancerTheodore D Koreckij, Charles Hill, Larry Azure, et al.
The Prostate|June 29, 2010
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viabilityColm Morrissey, Alex Dowell, Theodore D Koreckij, et al.
Molecular Cancer|July 6, 2010
Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral bloodMatthias Jost, John R Day, Ryan Slaughter, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
HE3235 inhibits growth of castration-resistant prostate cancerTheodore D Koreckij, Richard J Trauger, Robert Bruce Montgomery, et al.
Pageof 1